EdwardPatrickIngenitoMD
Pulmonology • Boston, MACritical Care Medicine
Assistant Professor of Medicine, Brigham and Women's Hospital
Dr. Ingenito is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
75 Francis Street
Ca 318 Brigham And Womens Hospital Pulmonary Division
Boston, MA 02115Phone+1 617-732-7420- Is this information wrong?
Education & Training
Brigham and Women's HospitalResidency, Internal Medicine, 1984 - 1987- Brigham and Women's HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 1982 - 1984
Harvard Medical SchoolClass of 1982
Certifications & Licensure
MA State Medical License 1986 - 2025- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 598 citationsTezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del.Jennifer L Taylor-Cousar, Anne Munck, Edward F McKone, Cornelis K van der Ent, Alexander Moeller, Christopher Simard, Linda T Wang, Edward P Ingenito, Charlotte McKee,...> ;The New England Journal of Medicine. 2017 Nov 23
- 328 citationsTezacaftor–Ivacaftor in Residual-Function Heterozygotes with Cystic FibrosisSteven M. Rowe, Cori L. Daines, Felix C. Ringshausen, Eitan Kerem, John W Wilson, Elizabeth Tullis, Nitin Nair, Christopher Simard, Linda Han, Edward P. Ingenito, Char...> ;The New England Journal of Medicine. 2017 Nov 3
- 51 citationsBiomarker Profiles in Asthma With High vs Low Airway Reversibility and Poor Disease Control.William W. Busse, Stephen T. Holgate, Sally W. Wenzel, Paul Klekotka, Yun Chon, J. Feng, Edward P. Ingenito, Ajay Nirula> ;Chest. 2015 Dec 1
- Join now to see all
Grant Support
- Pneumografting - A Novel Cell-Based Therapy For EmphysemaNational Heart, Lung, And Blood Institute2007–2010
- Pneumoreductive Surfactant Therapy For EmphysemaNational Heart, Lung, And Blood Institute2007
- Pneumoreductive Surfactant Therapy For EmphysemaNational Heart, Lung, And Blood Institute2006–2007
- Force Propagation Of Emphysema In VivoNational Heart, Lung, And Blood Institute2004–2007
- Responses To Surgical And Bronchoscopic Volume ReductionNational Heart, Lung, And Blood Institute2002–2006
- Free Radical Induced Surfactant Dysfunction In Acute Lung InjuryNational Heart, Lung, And Blood Institute1996–2005
- Pneumedoreductive Surfacant - New Therapy For EmphysemaNational Heart, Lung, And Blood Institute2004
- Free Radical Induced Surfactant Dysfunction In Acute Lung InjuryNational Heart, Lung, And Blood Institute1996–2002
- Lung Volume Reduction Using A Bronchoscopic ApproachNational Heart, Lung, And Blood Institute1999–2000
- Determinants Of Tissue ResistanceNational Heart, Lung, And Blood Institute1993–1995
- Determinants Of Tissue Resistance In The Guinea PIGNational Heart, Lung, And Blood Institute1991–1992
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
